126
G. R. Stephenson, I. M. Palotai / Tetrahedron Letters 54 (2013) 123–127
Bartoszek, M.; Flatau, S. Planta Med. 1995, 61, 564–566; Our synthetic
17. (a) Birch, A. J.; Cross, P. E.; Lewis, J.; Wild, S. B. J. Chem. Soc. A 1968, 332–340; (b)
Birch, A. J.; Chamberlain, K. B. Org. Synth. 1977, 57, 107–112.
approach: (e) Stephenson, G. R.; Balfe, A. M.; Hughes, D. L.; Kelsey, R. D.
Tetrahedron Lett. 2010, 51, 6806–6809; (f) Anson, C. E.; Hartmann, S.; Kelsey, R.
D.; Stephenson, G. R. Polyhedron 2000, 19, 569–571; (g) Astley, S. T.; Meyer, M.;
Stephenson, G. R. Tetrahedron Lett. 1993, 34, 2035–2038; (h) Astley, S. T.;
Stephenson, G. R. J. Chem. Soc., Perkin Trans. 1 1992, 1953–1955; (i) Astley, S. T.;
Stephenson, G. R. Synlett 1992, 507–509.
18. This unstable dienone complex showed the characteristic high frequency ms
vibrational band at 2086 cmÀ1 in the IR spectrum recorded in cyclohexane (this
is too high for a normal tricarbonyliron
g
4-diene complex). The expected ester
(1735 cmÀ1) and ketone (1660 cmÀ1) vibrations were also observed.
19. The racemic complexes are suitable to establish regiocontrol effects, but
enantiomerically pure complexes for use in applications of the stereodominant
5. Isolation of lycoramine: (a) Kobayashi, S.; Yuasa, K.; Imakura, Y.; Kihara, M.;
Shingu, T. Chem. Pharm. Bull. 1980, 28, 3433–3436; (b) Kobayashi, S.; Shingu, T.;
Uyeo, S. Chem. Ind. (London) 1956, 177–178; (c) Kondo, H.; Tomimura, K.;
Ishiwata, S. J. Pharm. Soc. Jpn. 1932, 52, 433–458; (d) Kondo, H.; Ishiwata, S.
Chem. Ber. 1937, 70, 2427–2437; (e) Uyeo, S.; Kobayashi, S. Pharm. Bull. 1953, 1,
139–142; (f) Analogues of galanthamine and lycoramine have activity as
modulators of nicotinic receptors, see: Davis, B. U.S. Patent 148253, 2002.; (g)
Davis, B. PCT Int. Appl. WO 2001043697, 2001.; (h) Disorders of attention (e.g.,
attention deficit disorder or Tourette’s syndrome) have been treated by
administering lycoramine, O-desmethyllycoramine, or an ester, ether,
carbamate or carbonate derivative: Davis, B. M. PCT Int. Appl. WO 9921561,
1999.; Our synthetic approach: (i) Sandoe, E. J.; Stephenson, G. R.; Swanson, S.
Tetrahedron Lett. 1996, 37, 6283–6286.
group methodology are available by
a variety of methods, for example:
enantioface-selective asymmetric complexation: (a) Knölker, H.-J. Chem. Rev.
2000, 100, 2941–2961; (b) Knölker, H.-J.; Herzberg, D. Tetrahedron Lett. 1999,
40, 3547–3548; (c) Berger, D.; Dubs, M.; Göbel, A.; Imhof, W.; Kötteritzsch, M.;
Rost, M.; Schönecker, B. Tetrahedron: Asymmetry 1999, 10, 2983–2995; (d)
Knölker, H.-J.; Goesmann, H.; Hermann, H.; Herzberg, D.; Rohde, G. Synlett
1999, 421–425; (e) Knölker, H.-J.; Hermann, H.; Herzberg, D. Chem. Commun.
1999, 831–832; (f) Maywald, F.; Eilbracht, P. Synlett 1996, 380–382; (g)
Knölker, H.-J.; Hermann, H. Angew. Chem., Int. Ed. 1996, 35, 341–344; (h) Birch,
A. J.; Raverty, W. D.; Stephenson, G. R. Organometallics 1984, 3, 1075–1079; (i)
Birch, A. J.; Stephenson, G. R. Tetrahedron: Asymmetry 1981, 22, 779–882; (j)
Birch, A. J.; Raverty, W. D.; Stephenson, G. R. Tetrahedron Lett. 1980, 21, 197–
200; enantiotopic group selectivity in asymmetric hydride abstraction: (k)
Magdziak, D.; Pettus, L. H.; Pettus, T. R. R. Org. Lett. 2001, 3, 557–559; (l) Older,
J. E. J. Ph.D. Thesis, University of East Anglia, 2001.; (m) Older, J. E. J.;
Stephenson, G. R. Unpublished results.; Diastereoface selective complexation
of enantiopure dienes: (n) Birch, A. J. Ann. N. Y. Acad. Sci. 1980, 333, 107; (o)
Palframan, M. J.; Kociok-Köhn, G.; Lewis, S. E. Chem. Eur. J. 2012, 18, 4766–
4774; (p) Palframan, M. J.; Kociok-Köhn, G.; Lewis, S. E. Org. Lett. 2011, 13,
3150–3153; (q) Pilgrim, S.; Kociok-Köhn, G.; Lloyd, M. D.; Lewis, S. E. Chem.
Commun. 2011, 47, 4799–4801; (r) Griffen, J. A.; le Coz, A. M.; Kociok-Köhn, G.;
Ali Khan, M.; Stewart, A. J. W.; Lewis, S. E. Org. Biomol. Chem. 2011, 9, 3920–
3928; (s) Ali Khan, M.; Mahon, M. F.; Stewart, A. J. W.; Lewis, S. E.
Organometallics 2010, 29, 199–204; (t) Ali Khan, M.; Lowe, J. P.; Johnson, A.
L.; Stewart, A. J. W.; Lewis, S. E. Chem. Commun. 2011, 47, 215–217; (u) Anson,
C. E.; Dave, G.; Stephenson, G. R. Tetrahedron: Asymmetry 2000, 56, 2273–2281;
(v) Pearson, A. J.; Gelormini, A. M.; Pinkerton, A. A. Organometallics 1992, 11,
936–938; (w) Stephenson, G. R.; Howard, P. W.; Taylor, S. C. J. Organomet.
Chem. 1991, 419, C14–C17; (x) Howard, P. W.; Stephenson, G. R.; Taylor, S. C.
Chem. Commun. 1990, 1182–1184; (y) Howard, P. W.; Stephenson, G. R.; Taylor,
S. C. J. Organomet. Chem. 1989, 370, 97–109; (z) Howard, P. W.; Stephenson, G.
R.; Taylor, S. C. Chem. Commun. 1988, 1603–1604; resolution: (aa) Birch, A. J.;
Bandara, B. M. R. Tetrahedron Lett. 1980, 21, 2981–2982; (ab) Stephenson, G. R.
Aust. J. Chem. 1981, 34, 2339–2345; (ac) Atton, J. G.; Evans, D. J.; Kane-Maguire,
L. A. P.; Stephenson, G. R. Chem. Commun. 1984, 1246–1248; (ad) Palotai, I. M.;
Stephenson, G. R.; Kane-Maguire, L. A. P. J. Organomet. Chem. 1987, 319, C5–
C10; (ae) Birch, A. J.; Kelly, L. F.; Weerasuria, D. V. J. Org. Chem. 1988, 53, 278–
281; (af) Bandara, B. M. R.; Birch, A. J.; Kelly, L. F. J. Org. Chem. 1984, 49, 2496–
2498; Kinetic resolution: (ag) Atton, J. G.; Kane-Maguire, L. A. P.; Williams, P.
A.; Stephenson, G. R. . J. Organomet. Chem. 1982, 232, C5–C8; For determination
of absolute configurations and CD correlations, see: ah Birch, A. J.; Raverty, W.
D.; Stephenson, G. R. J. Organomet. Chem. 1981, 46, 5166–5172; (ai) Birch, A. J.;
Raverty, W. D.; Stephenson, G. R. Chem. Commun. 1980, 857–859;
Measurement of ee: (aj) Stephenson, G. R. Aust. J. Chem. 1982, 35, 1939–1943.
20. The reaction mixture was filtered through a pad of celite to remove pyrophoric
iron particles, and then concentrated on a rotary evaporator fitted with a dry
ice cooled condenser (caution: pentacarbonyliron in distillate) and then
Kugelrohr distilled. In practice, the recovered diene can be recycled by
returning it to the blackened reaction vessel (in our experience this is more
effective than using a clean flask, and also more convenient), adding additional
pentacarbonyliron and heating at reflux for 8–10 h. For a description of this
recycling procedure, see: Curtis, H.; Johnson, B. F. G.; Stephenson, G. R. J. Chem.
Soc., Dalton Trans. 1985, 1, 1723–1725.
6. Stephenson, G. R.; Roe, C.; Sandoe, E. J. Eur. J. Org. Chem. 2011, 1664–1681.
7. Isolation of maritidine: (a) Rao, R. V. K.; Rao, J. V. L. N. S. Curr. Sci. 1979, 48, 110–
111; (b) Herrera, M. R.; Machocho, A. K.; Brun, R.; Viladomat, F.; Codina, C.;
Bastida, J. Planta Med. 2001, 67, 191–193; Our synthetic approach: (c) Roe, C.;
Stephenson, G. R. Org. Lett. 2008, 10, 189–192.
8. Seebach, D. Angew. Chem., Int. Ed. Engl. 1979, 18, 239–258.
9. The working ligand is the portion of the multihapto metal complex that is
stoichiometrically incorporated into the target molecule, see: (a) Stephenson,
G. R. Advanced Asymmetric Synthesis; Chapman & Hall: London, 1996; (b) Anson,
C. E.; Hudson, R. D. A.; Smyth, D. G.; Stephenson, G. R. Appl. Organomet. Chem.
2001, 15, 16–22; Examples of working ligands in synthesis: (c) Owen, D. A.;
Malkov, A. V.; Palotai, I. M.; Roe, C.; Sandoe, E. J.; Stephenson, G. R. Chem. Eur. J.
2007, 13, 4293–4311; (d) Stephenson, G. R.; Anson, C. E.; Malkov, A. V.; Roe, C.
Eur. J. Org. Chem. 2012, 4716. alkaloid synthesis; (e) Stephenson, G. R. J. Chem.
Soc., Perkin Trans.
Stephenson, G. R. J. Chem. Soc., Perkin Trans.
1
1982, 2449–2456; (f) Alexander, R. P.; Morley, C.;
1988, 2069–2074; (g)
1
Alexander, R. P.; Stephenson, G. R. J. Chem. Soc., Dalton Trans. 1987, 885–888;
(h) Pearson, A. J.; O’Brien, M. K. J. Org. Chem. 1989, 54, 4663–4673; (i) Chandler,
M.; Mincione, E.; Parsons, P. J. J. Chem. Soc., Chem. Commun. 1985, 1233–1234;
(j) Pearson, A. J.; Heywood, G. C.; Chandler, M. J. Chem. Soc., Perkin Trans. 1 1982,
2631. terpene synthesis; (k) Dunn, M. J.; Jackson, R. F. W.; Stephenson, G. R.
Synlett 1992, 905–906. amino acid synthesis; (l) Tao, C.; Donaldson, W. A. J. Org.
Chem. 1993, 58, 2134–2143; (m) Franck-Neumann, M.; Colson, P.-J. Synlett
1991, 891–894; (n) Gigou, A.; Beaucourt, J.-P.; Lellouche, J.-P.; Grée, R.
Tetrahedron Lett. 1991, 32, 635–638; (o) Birch, A.; Dahler, J. P.; Narula, A. S.;
Stephenson, G. R. Tetrahedron Lett. 1980, 21, 3817–3820. prostaglandins and
leukotrienes; (p) Börger, C.; Krahl, M. P.; Gruner, M.; Kataeva, O.; Knölker, H.-J.
Org. Biomol. Chem. 2012, 10, 5189–5193; (q) Thomas, C.; Kataeva, O.; Knölker,
H.-J. Synlett 2011, 2663–2666; (r) Knott, K. E.; Auschill, S.; Jäger, A.; Knölker, H.-
J. Chem. Commun. 2009, 1467–1469; (s) Choi, T. A.; Czerwonka, R.; Forke, R.;
Jäger, A.; Knöll, J.; Krahl, M. P.; Krause, T.; Reddy, K. R.; Franzblau, S. G.; Knölker,
H.-J. Med. Chem. Res. 2008, 17, 374–385; (t) Kataeva, O.; Krahl, M. P.; Knölker,
H.-J. Org. Biomol. Chem. 2005, 3, 3099–3101; (u) Knölker, H.-J.; Bauermeister, M.
Tetrahedron: Asymmetry 1993, 49, 11221–11236; (v) Knölker, H.-J.;
Bauermeister, M. Chem. Commun. 1990, 664–665; (w) Birch, A. J.; Liepa, A. J.;
Stephenson, G. R. J. Chem. Soc., Perkin Trans. 1 1982, 1, 713–717. carbazole
alkaloids.
10. This is illustrated in our synthesis of O-methyl joubertiamine: Stephenson, G.
R.; Finch, H.; Owen, D. A.; Swanson, S. Tetrahedron: Asymmetry 1993, 49, 5649–
5662.
11. Isolation of parkacine: Doepke, W. Naturwissenschaft 1963, 50, 645.
pancratistatin is
parkacine.
a
more simple structure because it lacks the
D
ring of
21. (a) Birch, A. J.; Haas, M. A. J. Chem. Soc. C 1971, 2465–2467; (b) Meng, W. D.;
Stephenson, G. R. J. Organomet. Chem 1989, 371, 355–360; (c) Stephenson, G. R.;
Owen, D. A.; Finch, H.; Swanson, S. Aust. J. Chem. 1992, 45, 121–134.
22. Birch, A. J.; Kelly, L. F.; Thompson, D. J. J. Chem. Soc., Perkin Trans. 1 1981, 1006–
1012.
12. Palotai, I. M.; Stephenson, G. R.; Ross, W. J.; Tupper, D. E. J. Organomet. Chem.
1989, 364, C11–C14.
13. 1-Methoxy-2-(2,2,2-trimethoxyethyl)benzene is commercially available in
gram quantities from specialist suppliers.
23. (a) Ainsworth, C.; Chen, F.; Kuo, Y.-N. J. Organomet. Chem. 1972, 46, 59–71; (b)
Burlachenko, G. S.; Baukov, Yu. I.; Lutsenko, I. F. Zh. Obshch. Khim. 1972, 42,
387–391; Examples of recent use: (c) Palmieri, A.; Petrini, M. Org. Biomol. Chem.
2012, 10, 3486–3493; (d) Chua, S.-S.; Alni, A.; Chan, L.-T. J.; Yamane, M.; Loh, T.-
P. Tetrahedron: Asymmetry 2011, 67, 5079–5082; Nucleophilicity: (e) Deuri, S.;
Phukan, P. Indian J. Chem. 2010, 49A, 1206–1211; Deuri, S.; Phukan, P. J. Mol.
Struct. THEOCHEM 2010, 945, 64–70.
14. Salt 1 1H NMR dH (400 MHz, CD3CN) 6.95 (1H, d, J = 6 Hz, H-3), 5.84 (1H,
apparent t, J = 6 Hz, H-4), 4.33 (1H, apparent t, J = 6 Hz, H-5), 4.04 (3H, s,
CO2Me), 3.66 (3H, s, OMe), 3.09 (1H, d, J = 17 Hz, CH2CO2), 3.02 (1H, dd, J = 15,
6 Hz, H-6b), 2.91 (1H, d, J = 17 Hz, CH2CO2), 2.32 (1H, d, J = 15 Hz, H-6a); dC
199.6 (FeCO), 169.7 (CO2–), 148.4 (C-2), 98.1 (C-4), 72.7 (C-3), 66.9 (C-5), 58.4
(OMe), 56.2 (C-1), 52.9 (OMe), 37.3 (CO2–), 33.1 (C-6) ppm.
15. Microanalytical data: Salt 1: Found: C, 33.3; H, 2.7. C13H13F6FeO6P requires C,
33.5; H, 2.8. Regioisomeric diene complexes 4 and 5: Found: C, 48.9; H, 4.4.
24. Salt 9: 1H NMR dH (400 MHz, CD3CN) 6.05 (1H, d, J = 8 Hz, H-4), 4.14 (3H, s,
OMe), 4.00 (1H, m, H-1), 3.88 (1H, m, H-5), 3.86 (1H, d, J = 16 Hz, CH2CO2), 3.73
(3H, s, CO2Me), 3.03 (1H, d, J = 16 Hz, CH2CO2), 2.93 (dt, J = 15, 6 Hz, H-6b), 1.83
C13H14FeO6 requires C, 48.5; H, 4.4. Salt 8: Found: C, 47.7; H, 4.6. C14H16FeO7
requires C, 47.8; H, 4.6. Salt 9: Found: C, 33.4; H, 2.6. C13H13F6FeO6P requires C,
33.5; H, 2.8. Regioisomeric diene complexes 10 and 11: Found: C, 48.1; H, 4.3.
(dt, J = 15, 1.8 Hz, H-6a) ppm.
25. Salt 2: 1H NMR dH (400 MHz, CD3CN) 6.00 (1H, d, J = 7 Hz, H-4), 3.80 (3H, s,
CO2Me), 3.64 (3H, s, OMe), other signals obscured by signals of 1; 13C NMR dC
199.6 (FeCO), 171.7 (CO2–), 154.3 (C-2), 101.6 (C-4), 91.2 (C-3), 62.0 (C-5), 58.4
(OMe), 53.2 (OMe) 41.5 (C-1), 33.5 (CH2CO2), 27.3 (C-6) ppm.
C13H14FeO6 requires C, 48.5; H, 4.4.
16. The salt 1 was purified by simple precipitation from acetonitrile by addition of
diethyl ether, and appeared pure by NMR, However, a trace amount (ca. 4%) of
the regioisomeric phenyl derivative 13 was identified in the NMR spectrum of
the products from reaction with diphenylzinc. When 1 is prepared on a large
scale, repeated precipitation improves the purity. It is anticipated that the
route described here will be more suitable than the original procedure (Ref. 12)
for access on a large scale.
26. Stephenson, G. R.; Palotai, I. M.; Ross, W. J.; Tupper, D. E. Synlett 1991, 586–588.
27. Phenylation product 12 from the
x
addition pathway to 1: 1H NMR dH
(400 MHz, CDCl3) 7.20 (5H, m, Ar-H), 5.05 (1H, d, J = 6.5 Hz, H-3), 3.77 (3H,
OMe), 3.72 (3H, OMe), 3.23 (1H, dt, J = 11, 6.5 Hz, H-5), 3.04 (2H, s, CH2CO2),
2.71 (1H, dd, J = 6.5, 3.5, H-4), 2.45 (1H, dd, J = 14.5, 11 Hz, H-6b), 1.94 (1H, dd,